Allopurinol interference with a diagnostic test can lead to a false diagnosis of which condition?

Allopurinol interference with a diagnostic test can lead to a false diagnosis of which condition?

• A. Diabetes Mellitus
• B. Gout
• C. Hyperlipidemia
• D. Tuberculosis

Answer: (C)

All drugs can affect how lab tests read, so sometimes a test result reflects interference from a medication rather than the patient’s true condition. In this case, some lipid tests use enzymatic colorimetric methods that can be influenced by substances in the blood. Allopurinol or its metabolites can interfere with these reactions enough to make cholesterol or triglyceride levels appear higher than they truly are, leading to a false impression of hyperlipidemia. If a patient is on allopurinol and a lipid panel comes back unexpectedly elevated, clinicians might repeat the test later or use a different assay to verify, rather than assuming true hyperlipidemia. The other conditions listed are diagnosed by tests and clues that aren’t as commonly affected by allopurinol interference in the same way, so they’re less likely to produce a false-positive result due to this drug.

All drugs can affect how lab tests read, so sometimes a test result reflects interference from a medication rather than the patient’s true condition. In this case, some lipid tests use enzymatic colorimetric methods that can be influenced by substances in the blood. Allopurinol or its metabolites can interfere with these reactions enough to make cholesterol or triglyceride levels appear higher than they truly are, leading to a false impression of hyperlipidemia.

If a patient is on allopurinol and a lipid panel comes back unexpectedly elevated, clinicians might repeat the test later or use a different assay to verify, rather than assuming true hyperlipidemia. The other conditions listed are diagnosed by tests and clues that aren’t as commonly affected by allopurinol interference in the same way, so they’re less likely to produce a false-positive result due to this drug.